Pharmaceutical Products Eligible for Export
| abacavir (ABC) |
tablet, 300 mg (as sulfate); oral solution, 100 mg (as sulfate)/5
mL |
| abacavir + lamivudine + zidovudine |
tablet, 300 mg (as sulfate) + 150 mg + 300 mg |
| aciclovir |
tablet, 200 mg; powder for injection, 250 mg (as sodium salt) in
vial |
| amphotericin B |
powder for injection, 50 mg in vial |
| amprenavir |
tablet, 150 mg; capsule, 50 mg or 150 mg; oral solution, 15 mg/mL |
| azithromycin |
capsule, 250 mg or 500 mg; suspension, 200 mg/5 mL |
| beclometasone |
inhalation (aerosol), 50 micrograms per dose (dipropionate) or 250 micrograms (dipropionate) per dose |
| ceftazidime |
powder for injection, 250 mg (as pentahydrate) in vial |
| ceftriaxone |
injection, 500 mg (as sodium); powder for injection, 250 mg (as
sodium salt) in vial |
| ciclosporin |
capsule, 25 mg; concentrate for injection, 50 mg/mL in 1-mL ampoule
(for organ transplantation) |
| ciprofloxacin |
tablet, 250 mg (as hydrochloride) |
| ciprofloxacin |
tablet, 250 mg or 500 mg |
| daunorubicin |
powder for injection, 50 mg (as hydrochloride) in vial |
| delavirdine |
capsule or tablet, 100 mg (as mesylate) |
| didanosine (ddI) |
buffered chewable, dispersible tablet, 25 mg, 50 mg, 100 mg, 150 mg, 200 mg; buffered powder for oral solution, 100 mg, 167 mg, 250 mg, packets; unbuffered enteric coated capsule, 125 mg, 200 mg, 250 mg, 400 mg |
| diphtheria antitoxin |
injection, 10,000 IU or 20,000 IU in vial |
| diphtheria vaccine |
|
| doxorubicin |
powder for injection, 10 mg or 50 mg (hydrochloride) in vial |
| efavirenz (EFV or EFZ) |
capsule, 50 mg, 100 mg or 200 mg; oral solution, 150 mg/5 mL |
| eflornithine |
injection, 200 mg (hydrochloride)/mL in 100-mL bottles |
| enalapril |
tablet, 2.5 mg |
| erythromycin |
capsule or tablet, 250 mg (as stearate or ethyl succinate); powder
for oral suspension, 125 mg (as stearate or ethyl succinate); powder
for injection, 500 mg (as lactobionate) in vial |
| etoposide |
capsule, 100 mg; injection, 20 mg/mL in 5-mL ampoule |
| factor IX (complex coagulation factors II, VII, IX, X) concentrate |
dried |
| hepatitis B vaccine |
|
| ibuprofen |
tablet, 200 mg or 400 mg |
| indinavir (IDV) |
capsule, 200 mg, 333 mg or 400 mg (as sulfate) |
| insulin injection (soluble) |
injection, 40 IU/mL in 10-mL vial or 100 IU/mL in 10-mL vial |
| intermediate-acting insulin |
injection, 40 IU/mL in 10-mL vial; 100 IU/mL in 10-mL vial (as compound
insulin zinc suspension or isophane insulin) |
| isoniazid + pyrazinamide + rifampin |
tablet, 50 mg + 300 mg + 120 mg |
| ivermectin |
scored tablet, 3 mg or 6 mg |
| lamivudine (3TC) |
capsule or tablet, 150 mg; oral solution 50 mg/5 mL |
| lamivudine + nevirapine + zidovudine |
tablet, 150 mg + 200 mg + 300 mg |
| lamivudine + zidovudine |
tablet, 150 mg + 300 mg |
| levodopa + carbidopa |
tablet, 100 mg + 10 mg or 250 mg + 25 mg |
| levofloxacin |
tablet, 250 mg or 500 mg |
| lithium carbonate |
capsule or tablet, 300 mg |
| lopinavir + ritonavir (LPV/r) |
capsule, 133.3 mg + 33.3 mg; oral solution, 400 mg + 100 mg/5 mL |
| metoclopramide |
tablet, 10 mg (hydrochloride); injection, 5 mg (hydrochloride)/mL
in 2-mL ampoule |
| metronidazole |
tablet, 250 mg or 500 mg; injection, 500 mg in 100-mL vial; suppository,
500 mg or 1 g; oral suspension, 200 mg (as benzoate)/5 mL |
| morphine |
injection, 10 mg in 1mL ampoule (sulfate or hydrochloride);
oral solution, 10 mg (hydrochloride or sulfate)/5mL; tablet,
10 mg (sulfate) |
| nelfinavir (NFV) |
tablet, 250 mg (as mesilate); oral powder, 50 mg/g |
| nevirapine (NVP) |
tablet, 200 mg; oral suspension, 50 mg/5 mL |
| nifedipine |
sustained release formulations, tablet, 10 mg |
| nitrofurantoin |
tablet, 100 mg |
| ofloxacin |
tablet, 200 mg or 400 mg |
| potassium chloride |
powder for solution |
| ranitidine |
tablet, 150 mg (as hydrochloride); oral solution, 75 mg/5 mL; injection,
25 mg/mL in 2-mL ampoule |
| ritonavir |
capsule, 100 mg; oral solution, 400 mg/5 mL |
| salbutamol |
tablet, 2 mg or 4 mg (as sulfate); inhalation (aerosol), 100 micrograms
(as sulfate) per dose; syrup, 2 mg/5 mL; injection, 50 micrograms
(as sulfate)/mL in 5-mL ampoule; respirator solution for use in nebulizers,
5 mg (as sulfate)/mL |
| saquinavir (SQV) |
capsule, 200 mg |
| stavudine (d4T) |
capsule, 15 mg, 20 mg, 30 mg or 40 mg; powder for oral solution,
5 mg/5 mL |
| testosterone |
injection, 200 mg (enantate) in 1-mL ampoule |
| timolol |
solution (eye drops), 0.25% or 0.5% (as maleate) |
| verapamil |
tablet, 40 mg or 80 mg (hydrochloride); injection, 2.5 mg (hydrochloride)/mL
in 2-mL ampoule |
| zalcitabine |
capsule or tablet, 0.375 mg or 0.750 mg |
| zidovudine (ZDV or AZT) |
tablet, 300 mg; capsule, 100 mg or 250 mg; oral solution or syrup,
50 mg/5 mL; solution for IV infusion injection, 10 mg/mL in 20-mL
vial |
